Editorial & Opinion
أعرض في EDS

Confronting Treatment Disparities in Chronic Limb-Threatening Ischemia.

التفاصيل البيبلوغرافية
العنوان: Confronting Treatment Disparities in Chronic Limb-Threatening Ischemia.
المؤلفون: Butala NM; Rocky Mountain Regional VA Medical Center, Aurora, CO (N.M.B.).; University of Colorado School of Medicine, Aurora (N.M.B.)., Shah B; Veterans Affairs New York Harbor Health Care System (B.S.).; New York University School of Medicine (B.S.).
المصدر: Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2024 Jan; Vol. 17 (1), pp. e013693. Date of Electronic Publication: 2023 Dec 28.
نوع المنشور: Editorial; Comment
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101499602 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-7632 (Electronic) Linking ISSN: 19417640 NLM ISO Abbreviation: Circ Cardiovasc Interv Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, MD : Lippincott Williams & Wilkins
مواضيع طبية MeSH: Peripheral Arterial Disease*/diagnostic imaging , Peripheral Arterial Disease*/therapy , Endovascular Procedures*, Humans ; Chronic Limb-Threatening Ischemia ; Treatment Outcome ; Chronic Disease ; Ischemia/diagnostic imaging ; Ischemia/therapy ; Limb Salvage ; Retrospective Studies ; Risk Factors
مستخلص: Competing Interests: Disclosures No disclosures relevant to this editorial. Dr. Butala is a consultant for Shockwave Medical and reports receipt of personal fees from HiLabs outside the submitted work. Dr. Binita Shah receives grant funding from the NIH NHLBI (1R01HL146206, 3R01HL146206-02S1) and VA Office of Research and Development (CSP 2002, I01CX002358); serves on the advisory boards for Philips Volcano; serves on the steering committee for ARTEMIS (NovoNordisk), CLEAR SYNERGY (PHRI) and IMPROVE (Washington Hospital Center) trials; serves on the DSMB for Heartflow’s PRECISE trial, Encompass ET02, Magictouch™ Sirolimus-Coated Balloon For Treatment Of Coronary Artery Lesions With In-Stent Restenosis (Cardiovascular Research Foundation); serves on the Clinical Events Committees for Abbott’s SPIRIT-48 and Concept Medical’s ABILITY-DM trials (Icahn School of Medicine at Mount Sinai) and DEFINE-GPS, Magenta Medical’s ELEVATE II trials, and Cardiac Dimensions-The EMPOWER Trial (Cardiovascular Research Foundation).
التعليقات: Comment on: Circ Cardiovasc Interv. 2024 Jan;17(1):e012798. (PMID: 38152880)
References: J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40. (PMID: 31159978)
Circulation. 2017 Mar 21;135(12):e726-e779. (PMID: 27840333)
J Vasc Surg. 2015 Dec;62(6):1642-51.e3. (PMID: 26391460)
J Am Heart Assoc. 2018 Aug 21;7(16):e009724. (PMID: 30369325)
J Vasc Surg. 2013 Jun;57(6):1471-79, 1480.e1-3; discussion 1479-80. (PMID: 23375611)
Circ Cardiovasc Interv. 2024 Jan;17(1):e012798. (PMID: 38152880)
Vasc Med. 2015 Feb;20(1):51-9. (PMID: 25659653)
JACC Cardiovasc Interv. 2018 May 28;11(10):1011-1012. (PMID: 29798766)
معلومات مُعتمدة: I01 CX002358 United States CX CSRD VA; IK2 CX001074 United States CX CSRD VA; R01 HL146206 United States HL NHLBI NIH HHS
فهرسة مساهمة: Keywords: Editorials; chronic limb-threatening ischemia; outcomes; peripheral artery disease; prognosis; threatening ischemia
تواريخ الأحداث: Date Created: 20231228 Date Completed: 20240118 Latest Revision: 20240329
رمز التحديث: 20240329
مُعرف محوري في PubMed: PMC10843778
DOI: 10.1161/CIRCINTERVENTIONS.123.013693
PMID: 38152882
قاعدة البيانات: MEDLINE
الوصف
تدمد:1941-7632
DOI:10.1161/CIRCINTERVENTIONS.123.013693